Global Microarray Market by Type (DNA, Protein), by Application (Disease Diagnostics, Drug Discovery, Research), by Product (Consumables, Software) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Summary of the Report

In 2018, the global microarray market was worth USD 3.90 billion. This market is expected to grow at 8.7% CAGR over the forecast period. Microarrays are used in a variety of areas, including basic molecular biology and toxicological response profiling. They also have high potential for biomarker identification and pharmaceutical target screening. This technology has been a success over the years due to its ability to simultaneously analyze thousands of genes.

Market growth is driven by a global rise in cancer incidence. A WHO report in 2018 estimated that global cancer incidences rose by 18.1 millions cases, resulting in 9.6 million deaths. The forecast period will also see a rise in healthcare R&D.

Market growth will also be driven by the increasing use of microarrays for various applications. Microarray analysis has been proven effective in antibiotic treatment, as the bacterial genome DNA is in most cases more than enough to survive. In such cases, DNA microarrays are often used because it allows for diagnosis to be made with a smaller amount of DNA than the larger number of bacteria required for culturing. The use of DNA-based microarrays for gene expression testing has been a popular choice in recent years. This can be attributed to factors like cost reduction and complexity, which allow the technology to become more accessible and standardized.

NGS is a cost-effective, precise, and affordable alternative to market growth. However, NGS's rapid development has made it possible. Market potential will also be limited by strict government regulations, standardization in microarray data, and a shortage of skilled professionals.

Product Insights

The market can be divided into three segments based on product: consumables (instruments), software & services (software & services), and consumables (consumables). Its large market share is due to its dominance in 2018 through repeated and bulk purchases of consumables for different research applications. Because of its constant use in research, this product segment will continue to dominate the market for the foreseeable future.

Leading market players have developed a wide variety of instruments, which has facilitated their increasing adoption. Thermo Fisher Scientific Inc. has products like the GeneChip Scanner, which aids in scanning next-generation high-density arrays to detect transcription and all-exon arrays. The Gene Chip Hybridization Oven, which allows for precise temperature and rotation of samples, is another product offered by the company. This allows successful hybridization.

Market potential will be boosted by a rising number of product launches in the software and services segments. PerperPRINT, a biotech firm, launched the PEPperCHIP Allergen Microarray in 2015. This device allows high throughput screening for IgE antibodies from serum and plasma. This product covers approximately 4022 allergen epitopes from the Immune Epitope Database. It allows for easy profiling immune responses in blood serum that are linked to immunizations, cancer, infectious diseases and other autoimmune disorders.

A portable fluorescence microarray imaging device that can connect to a smartphone was used to detect breast cancer gene expression, according to a Royal Society of Chemistry research paper. This technique uses interactive binding of Cy3 target DNA to probe DNA. These technological advancements are expected to make it easier to diagnose cancer and increase market growth.

Type Insights

The market can be divided into three types based on microarray type: DNA, protein, and other. The largest market share for DNA microarray was held in 2018 due to its broad range of applications, including gene expression analysis, transcription factor binding analysis, and genotyping, among other things.

Protein microarrays typically consist of several support surfaces, such as slides, slides, microtitre plate, beads, and nitrocellulose membranes. These supports can cause binding of proteins. Market growth is expected to be further fueled by the increasing use of protein microarrays in drug discovery and toxicology studies by top pharmaceutical and biopharmaceutical firms.

The research study also included MM chips, peptide and tissue microarrays. Novus Biologics LLC is a supplier of life science products. It offers a wide variety of tissue microarray products including human prostate tissue microarrays, human breast tissue microarrays, human skin tissue tissue microarrays, and other products that are used increasingly for disease diagnosis and market growth.

Application Insights

The market can be divided by application into drug discovery, research applications, disease diagnostics and other applications. The largest share of the market was held by research applications in 2018, due to an increase in government and private funding for genomics and proteomics research. In 2018, the UVic-Genome BC Proteomics Centre was funded by Genome Canada and Genome British Columbia with funding totaling USD 18 million. This money will be used to improve diagnosis and treatment of many diseases, including cancer and Alzheimer's. This funding will also be used to support research in personalized medicine, which is a rapidly growing field.

Many companies use microarrays in drug discovery. They are used to measure the expression patterns of different genes and generate data on gene function. This aids in the identification of suitable target patients for therapeutic evaluation in clinical trials. The DNA microarrays are extremely beneficial because they allow researchers to identify people with similar biological patterns, and to design drugs that treat specific disorders. Clinical trials often use microarrays extensively because they allow researchers to monitor gene expression changes due to drug treatments.

This technology has made it possible to use diagnostic biomarkers to diagnose cancer and other diseases. Gene expressions can be used to detect the presence of carcinoma in situ in the urinary bladder. Agilent's miRNA microarray for human is used in cancer research with miRNA gene expressions.

Microarrays can also be used for toxicological, genomic, and proteomic research. Some custom microarrays can be used to detect ischemic or non-ischemic heart disease. They are used to classify various cardiomyopathies, facilitating effective diagnosis.

End Use Insights

The market can be divided by end use into research and academic institutions and pharmaceutical and biotechnology firms, diagnostics labs, and other end-users. Due to an increase in microarrays' use in drug discovery and research, the market share held by academic institutions was the largest.

In a 2018 report by the NIH, microarrays were used in the discovery of a cancer drug treatment. A report by India Brand Equity Foundation (IBEF), published in 2018, shows that India's hospital and diagnostic centers sector has attracted USD 6 billion in Foreign Direct Investment (FDI). This is between 2000 and 2018. Market growth will be further fueled by increasing R&D investments within the healthcare sector.

Illumina Inc., Vanderbilt University of Colorado, Montreal Heart Institute, Partners Healthcare, and the University of Colorado signed four biobanking deals in 2016. These research institutes use Illumina's array platforms, such as the Infinium Expanded Multi-Ethnic Genotyping Array and Illumina sequencing systems, to genotype over 2,00,000. This allows them to gain insights into genetic factors that cause cancer, heart disease, and other disorders. Increasing collaborations like these are expected to improve healthcare and promote personalized medicine.

Strategic acquisitions by top companies that expand their product ranges will be a major driver of growth in the pharmaceutical and biotechnology markets. In 2016, Thermo Fischer Scientific Inc. purchased Affymetrix, which is a manufacturer of DNA microarrays. Affymetrix microarray products are widely used in gene expression and genetic variation analysis.

The demand for products from leading companies to diagnose diseases such as cancers, diet-related disorders, autoimmune disorders, and infectious diseases is expected to rise. Applied Microarrays Inc. offers custom arrays for diagnosing cancer and infectious diseases like Ebola, influenza, sepsis, among others. These products can also detect other diseases such as diet-related disorders like dysbiosis and general food intolerance, as well as autoimmune disorders such a celiac.

Regional Insights

Segmentation of the microarray market by region includes North America, Europe and Asia Pacific, Latin America, Middle East & Africa, Latin America, Latin America, Latin America and Latin America. Due to an increase in cancer patients in the U.S., North America accounted for the largest revenue share. The European Commission reports that the European government will fund $7.5 billion in R&D in biotechnology. This funding will facilitate a rise in microarrays in various European regions for genomic and proteomic research. The government of Denmark also plans to invest $14.94 million in 2017-2020 to fund a new genomic research centre that will facilitate increased microarray usage.

Due to the rising funding for the healthcare sector, the Asia Pacific region will also see significant growth. According to IBEF in 2018, India's healthcare sector received $679 million of investment. These government initiatives are expected to increase the demand for microarrays in research.

Market Share Insights & Key Companies

The market is dominated by Bio-Rad Laboratories, Agilent Technology, Inc., Thermo Fisher Scientific Inc., Illumina, Inc., PerkinElmer Inc., Merck KGaA, GE Healthcare, Molecular Devices, LLC, Arrayit Corp., and Microarrays, Inc.

Market growth will be driven by new product launches from leading companies. Thermo Fisher Scientific Inc. launched CarrierScan in 2017 which allows for cytogenic analysis with over 6000 genetic variations. To maximize revenue share, many companies use mergers and acquisitions as a major strategy. Thermo Fisher Scientific Inc. purchased Affymetrix Inc. in 2016 for $1.3 billion. This acquisition will further strengthen Thermo Fisher Scientific’s product portfolio.

Agilent Technologies Inc., a biotech company based in Colorado, USA, entered into a multi-year supply agreement with SomaLogic, Inc. for custom microarrays. Agilent will supply custom oligo microarrays to SomaLogic, Inc. for use in the detection nucleic acid using SOMAscan, which is SomaLogic’s protein measurement instrument. This agreement covers clinical and basic research, pharmaceutical discovery and development, diagnostics, and other areas.

Microarray Market Report Scope

The report covers segments

This report predicts revenue growth at the global, regional and country levels. It also provides analysis of industry trends in each sub-segment from 2015 to 2026. Grand View Research has divided the global microarray market report by product, type, application and end use.

• Product Outlook (Revenue USD Million, 2015-2026)

  • Consumables

  • Software and Services

  • Instruments

• Type Outlook (Revenue USD Million, 2015-2026)

  • DNA Microarrays

  • Protein Microarrays

  • Other Microarrays

• Application Outlook (Revenue USD Million, 2015-2026)

  • Research Applications

  • Drug Discovery

  • Diagnostics for Disease

  • Other Applications

• End Use Outlook (Revenue USD Million, 2015-2026)

  • Research & Academic Institutes

  • Companies in Pharmaceutical & Biotechnology

  • Diagnostic Laboratories

  • Other End Users

• Regional Outlook (Revenue USD Million, 2015-2026)

  • North America

    • U.S.

    • Canada

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Russia

  • Asia Pacific

    • Japan

    • China

    • India

    • South Korea

    • Australia

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East and Africa

    • South Africa

    • Saudi Arabia

    • UAE

These are the most frequently asked questions about this report

b. Global microarray market size was USD 4.14 billion in 2019, and is forecast to rise to USD 4.42 billion by 2020.

b. Global microarray markets are expected to expand at 8.7% compound annual growth rate from 2018 to 2026, to reach USD 7.4 Billion by 2026.

b. With a 42.1% share in 2019, DNA Microarrays was the dominant microarray company. Its wide-ranging applications in gene expression analysis and transcription factor binding analysis as well as genotyping are some of the reasons for this dominance.

b. Bio-Rad Laboratories, Agilent Technology, Inc., Thermo Fisher Scientific Inc., Illumina, Inc., PerkinElmer Inc., Merck KGaA, GE Healthcare, Molecular Devices, LLC, Arrayit Corp., and Microarrays, Inc. are some of the key players in the microarray marketplace.

b. The market growth is being driven by several key factors, including a global increase in cancer incidence and an increase in healthcare R&D. Also, microarrays are being used in many applications, such as gene expression, antibiotic treatment, and other medical procedures. NGS.

Up Market Research published a new report titled “Microarray Market research report which is segmented by Type (DNA, Protein), by Application (Disease Diagnostics, Drug Discovery, Research), by Product (Consumables, Software), By Players/Companies GE Healthcare, Illumina, Molecular Devices, Merck KGaA, Arrayit Corporation, PerkinElmer Inc, Microarrays, Inc, Agilent Technologies, Bio-Rad Laboratories, Inc, LLC, Thermo Fisher Scientific Inc, Inc”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Microarray Market Report Segments:

The market is segmented by Type (DNA, Protein), by Application (Disease Diagnostics, Drug Discovery, Research), by Product (Consumables, Software).

Microarray Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Microarray Market

Overview of the regional outlook of the Microarray Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Microarray Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Microarray Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. DNA

                2. Protein

                1. Disease Diagnostics

                2. Drug Discovery

                3. Research

                1. Consumables

                2. Software

9. Market scenario by region, sub-region, and country.
10. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
11. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
12. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Microarray Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Microarray Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.